CUSIP 52635N103COMLENZQ4 2025
25 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 4.18M | $66.86M |
| 2 | Fmr LLC | 3.70M | $59.24M |
| 3 | Alpha Wave Global, LP | 3.61M | $57.80M |
| 4 | Versant Venture Management, LLC | 2.66M | $42.51M |
| 5 | Blackrock, Inc. | 1.69M | $27.07M |
| 6 | Ubs Group AG | 1.57M | $25.15M |
| 7 | Vanguard Group Inc | 1.32M | $21.14M |
| 8 | Franklin Resources Inc | 1.10M | $17.54M |
| 9 | 72 Investment Holdings, LLC |
| 4 | Nov 14, 2025 | Paradigm Biocapital Advisors LP | 13G/A | 3.8% | 9.23B | SEC |
| 5 | Nov 14, 2025 | Point72 Asset Management, L.P. | 13G/A | 4.8% | 1.36M | SEC |
| 6 | Nov 10, 2025 | Versant Venture Capital Vi, L.P. | 13D/A | 3.4% | — | SEC |
| 7 | Nov 7, 2025 | Ra Capital Management, L.P. | 13D/A | 13.6% | — | SEC |
| 8 | Nov 7, 2025 | Fmr LLC | 13G | 15.0% | 4.28M | SEC |
| 9 | Oct 17, 2025 | Blackrock, Inc. | 13G | 5.1% | 1.44M | SEC |
| 10 | Sep 22, 2025 | Versant Venture Capital Vi, L.P. | 13D/A | 4.1% | — | SEC |
See the full Schedule 13D/13G history for Lenz Therapeutics Inc.
Unlock full history| 1.02M |
| $16.28M |
| 10 | Tang Capital Management LLC | 865.2K | $13.84M |